TNXP R&D Expense Growth
Tonix Pharmaceuticals Holding Corp · R&D Expense Growth
TNXP R&D Expense Growth
Latest reported9.98%period ending
TNXP FY R&D Growth (YoY) (0.00% → 9.98%)
Latest values, visible window
High-resolution chart · PNG
TNXP r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 9.9832% | |
| -53.3229% | |
| 5.8369% | |
| 18.9401% | |
| 90.3864% | |
| 98.7522% | |
| 3.6109% | |
| 31.5995% | |
| -53.2401% | |
| -19.6344% | |
| 90.7074% | |
| 300.3656% | |
| 80.0018% | |
| 123.0514% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |